MacroGenics, based in Rockville, Md., announced its acquisition of RavenBiotechnologies, based in San Francisco. Both biotechnology companies focus on treatment development of cancer and immune system-related therapeutics and are heavily venture backed. Company Web site
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.